Fulton Bank, N.A. Arrowhead Pharmaceuticals, Inc. Transaction History

Fulton Bank, N.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	SELL	$27.79 - $50.61 $126,916 - $231,135	-4,567 Closed	0 $0
Q1 2022 Apr 05, 2022	SELL	$39.62 - $69.97 $9,271 - $16,372	-234 Reduced 4.87%	4,567 $210,000
Q4 2021 Jan 05, 2022	BUY	$58.09 - $82.51 $4,531 - $6,435	78 Added 1.65%	4,801 $318,000
Q3 2021 Oct 05, 2021	BUY	$58.38 - $84.96 $37,771 - $54,969	647 Added 15.87%	4,723 $295,000
Q2 2021 Jul 06, 2021	BUY	$62.15 - $90.32 $15,475 - $22,489	249 Added 6.51%	4,076 $337,000
Q1 2021 Apr 05, 2021	BUY	$61.35 - $90.47 $9,877 - $14,565	161 Added 4.39%	3,827 $254,000
Q4 2020 Jan 07, 2021	BUY	$43.82 - $85.37 $160,644 - $312,966	3,666 New	3,666 $281,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Fulton Bank, N.A. with notifications on news.